Background: Significant inconsistencies between probe-to-gene annotations between different releases of probe set identifiers by commercial microarray platform solutions have been reported. Such inconsistencies lead to misleading or ambiguous interpretation of published gene expression results.
Results
Studying the cellular transcriptome and its dynamics using microarray technology has become a common place application in modern biomedical research [1] . Dedicated databases [i.e. [2] [3] [4] ] store several hundreds of individual microarray datasets and are growing exponentially. Many different commercial and research originating microarray formats and platforms are being used [2] [3] [4] . Since microarray technology currently can not be used to determine absolute expression levels of genes, comparative analysis of transcriptome data across different biological conditions is challenging. Cross-platform comparisons can only be carried out if coherent mapping of genes between the platforms and their particular probe-to-gene and geneto-genome annotations can be achieved. The public microarray databases are very valuable as here standard formatting and annotation procedures are being imposed, thereby rendering the individual microarray experiments useful beyond the immediate purpose they were acquired for [4, 5] .
Since both the genome sequences as well as individual gene annotations are subject to constant discovery-driven change, probe-to-gene annotations undergo frequent revisions. Such revisions of the initial probe-to-gene mapping lead to inconsistencies if they are not well controlled [6] . Today any dataset requires to be published together with the probe-to-gene annotation used for biological analysis or an explicit reference to a static open-source of such. Unfortunately, this is not state-of-the-art yet, and we join in the call for more sensitivity towards this issue [6] .
We show here that for Applied Biosystems AB1700 Genome Survey Arrays the same contention of potential inconsistencies in the probe-to-gene annotations holds true if several precautions are not taken.
Applied Biosystems AB1700 (ProdNo: 4338036) technology [7] , has only recently been commercialized and applied to biomedical research [8] . Design particularities such as the use of 60 mer oligonucleotide probes and the use of chemiluminescence as means of signal detection result in greater sensitivity as comparable commercial platforms. Until present microarray slides for human, mouse, and rat have been developed [7, [9] [10] [11] . For the Human Genome Survey Arrays (HGS) already a second generation of slides are being commercialized (2.0: ProdNo: 4359029, first release 1.0: ProdNo: 4337467), which contain probes for 29098 individual genes of which >8000 are not covered by other commercial solutions [9] (Figure 1 ).
The probe-sets as well as the probe-to-gene annotations (PGAs) for AB1700 technology are revised regularly. In order to assure correct and unambiguous interpretation of AB1700 data, we incite particular attention to the following aspects:
PGA revisions, unless tracked and conserved by the user lead to inconsistencies and ambiguities in the interpretation of AB1700 data Significant changes between probe-to-gene releases and microarray versions in Applied Biosystems AB1700 data are also observed. The conclusions drawn from the very same experimental dataset will differ depending on the particular PGA version used. In order to retain transparency, the microarray data need thus to be annotated with the PGA version used for interpretation. Currently, AB1700 PGA files are not date-stamped and simply replaced by revised versions in the AB Gene Expression System Software [12] once those become available. The AB1700 user has therefore to keep copies of back-versions and a mapping of datasets to PGA files. This problematic has been previously discussed for an analogous case [6] . AB1700 PGAs are not publicly available, and the PANTHER web-source can not be used for third party verifications Third parties have no direct access to the AB1700 PGA files. Independent verification of published results could thus only be achieved using the Applied Biosystems PAN-THER web-source which is similar in function to NetAffx [13] [14] [15] [16] . The user hereby can upload, temporally store, and analyze datasets containing gene or probe IDs and associated signal measurements. PANTHER's use of Hidden Markov Models (HHMs) and protein-family trees clearly provides for significant insights into the nature of the biologic problem studied, and is frequently used by research.
PANTHER internally operates on a continuously updated probe-to-gene annotation table, whereas the PGA releases are communicated discontinuously. Today there is no way of tracking and/or recording the continuous updates. PANTHER also contains only information on protein coding genes. The completeness of the internal PGA is further compromised by excluding GenBank-only mRNAs as they usually do not contain associated protein information. By consequence, published lists of gene or probe IDs with associated PANTHER pathways analyses are ambiguous, Venn diagrams comparing the different unique probe and gene sets according to probe-to-gene annotation releases and array versions potentially incomplete, and the interpretation is not necessarily verifiable by a third party.
Several probes for a single gene
Probe design for the AB1700 has been guided by the idea to have a single probe targeting all isoforms of a given gene. This is, due to alternative splicing, alternative promoter usage, and likely also to annotation errors, not possible for about 13% of all HGS V2.0 represented genes, which are consequently quantified using up to ten different probes on the array [9] [10] [11] 
Obsolete gene IDs and nomenclature suffixes
In the PGA table a specific column indicates whether the relationship between a given probe ID and the primary (Table 2) . Given above, since PANTHER is continuously updated, we suggest that submission files are generated and downloaded whenever PANTHER is used with AB1700 data, and that these files are carefully stored together with the biologic or statistic interpretation of the data.
Conclusion
The importance of unequivocal annotation of microarray experiments is evident. The analytical power of novel technologies such as the AB1700 platform from Applied Biosystems [7] certainly could be curtailed by incorrect annotation and failure to statically associate the correct annotations with the data.
In order to maintain a maximum of transparency and consistency, we conclude that such microarray data can only be analyzed based on probe IDs rather than gene IDs, and need to be supplemented with the following information for purposes of publication and reanalysis: (i) the microarray version, (ii) the probe-to-gene annotation release used, (iii) how multiple probes for a single gene, and (iv) how probe cross-reactivity have been considered. In case PANTHER was used for analysis: (v) which probe and gene corresponds to the HMM scores, and finally (vi) a submission record-file generated by PANTHER at the same time the statistical and biological analysis was performed.
Authors' contributions
SN and AB participated in the analysis of AB1700 data and their annotations, the computations, and manuscript preparation. AB has coordinated this study. Both authors have read and approved the final manuscript.
Additional material
